{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:53:29Z","timestamp":1784937209653,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.rmed.2021.106508","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T18:40:49Z","timestamp":1623782449000},"page":"106508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Evaluation of CD8+ response in QuantiFERON-TB Gold Plus as a marker of recent infection"],"prefix":"10.1016","volume":"185","author":[{"given":"Francisco","family":"Viana Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2021.106508_bib1","series-title":"Global Tuberculosis Report","author":"Organization","year":"2016"},{"key":"10.1016\/j.rmed.2021.106508_bib2","series-title":"Tuberculose em Portugal: Desafios e Estrat\u00e9gias","author":"Sa\u00fade","year":"2018"},{"key":"10.1016\/j.rmed.2021.106508_bib3","series-title":"Latent Tuberculosis Infection: Updated and Consolidated Guidelines for Programmatic Management. Latent Tuberculosis Infection: Updated and Consolidated Guidelines for Programmatic Management","year":"2018"},{"key":"10.1016\/j.rmed.2021.106508_bib4","doi-asserted-by":"crossref","first-page":"k2738","DOI":"10.1136\/bmj.k2738","article-title":"Revisiting the timetable of tuberculosis","volume":"362","author":"Behr","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.rmed.2021.106508_bib5","article-title":"Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease","volume":"288","author":"Emery","year":"2021","journal-title":"Proc. Biol. Sci."},{"issue":"4","key":"10.1016\/j.rmed.2021.106508_bib6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"L\u00f6nnroth","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106508_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.00114810","article-title":"Interferon-\u03b3 release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis","volume":"37","author":"Sester","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.rmed.2021.106508_bib8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1473-3099(18)30355-4","article-title":"Prognostic value of interferon-\u03b3 release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study","volume":"18","author":"Abubakar","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2021.106508_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1513\/AnnalsATS.201905-407RL","article-title":"Evaluation of QuantiFERON-TB gold Plus for predicting incident tuberculosis among recent contacts: a prospective cohort study","volume":"17","author":"Gupta","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"10.1016\/j.rmed.2021.106508_bib10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1164\/rccm.201905-0969OC","article-title":"Quantitative IFN-\u03b3 release assay and tuberculin skin test results to predict incident tuberculosis. A prospective cohort study","volume":"201","author":"Gupta","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2021.106508_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M17-0609","article-title":"Treatment of latent tuberculosis infection: an updated network meta-analysis","volume":"167","author":"Zenner","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.rmed.2021.106508_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmyco.2016.09.063","article-title":"Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB gold Plus kit","volume":"5","author":"Petruccioli","year":"2016","journal-title":"International Journal of Mycobacteriology"},{"key":"10.1016\/j.rmed.2021.106508_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tube.2018.06.005","article-title":"Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection","volume":"111","author":"Petrone","year":"2018","journal-title":"Tuberculosis"},{"issue":"6","key":"10.1016\/j.rmed.2021.106508_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jinf.2016.09.008","article-title":"First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus","volume":"73","author":"Petruccioli","year":"2016","journal-title":"J. Infect."},{"issue":"5","key":"10.1016\/j.rmed.2021.106508_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jinf.2019.08.018","article-title":"QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis","volume":"79","author":"Sotgiu","year":"2019","journal-title":"J. Infect."},{"issue":"9","key":"10.1016\/j.rmed.2021.106508_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01950-19","article-title":"Fourth-generation QuantiFERON-TB gold Plus: what is the evidence?","volume":"58","author":"Shafeque","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.rmed.2021.106508_bib18","article-title":"Comparing the diagnostic performance of QFT-plus to other tests of latent tuberculosis infection: a systematic review and meta-analysis","author":"Oh","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2021.106508_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01854-19","article-title":"Comparative results of QuantiFERON-TB gold in-tube and QuantiFERON-TB gold Plus assays for detection of tuberculosis infection in clinical samples","volume":"58","author":"Won","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.rmed.2021.106508_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jinf.2019.04.010","article-title":"Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases","volume":"79","author":"Chiacchio","year":"2019","journal-title":"J. Infect."},{"issue":"3","key":"10.1016\/j.rmed.2021.106508_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-015-0490-8","article-title":"CD8 T cells and Mycobacterium tuberculosis infection","volume":"37","author":"Lin","year":"2015","journal-title":"Semin. Immunopathol."},{"issue":"5","key":"10.1016\/j.rmed.2021.106508_bib22","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.1101122","article-title":"Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load","volume":"187","author":"Day","year":"2011","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2021.106508_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.diagmicrobio.2012.11.023","article-title":"Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection","volume":"75","author":"Nikolova","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"11","key":"10.1016\/j.rmed.2021.106508_bib24","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1164\/rccm.200306-837OC","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells","volume":"168","author":"Lewinsohn","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2021.106508_bib25","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02033-2015","article-title":"First independent evaluation of QuantiFERON-TB Plus performance","volume":"47","author":"Barcellini","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106508_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2019.01.007","article-title":"CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status","volume":"78","author":"Lee","year":"2019","journal-title":"J. Infect."},{"issue":"5","key":"10.1016\/j.rmed.2021.106508_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106508_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tube.2017.06.002","article-title":"Analytical evaluation of QuantiFERON- Plus and QuantiFERON- gold in-tube assays in subjects with or without tuberculosis","volume":"106","author":"Petruccioli","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.rmed.2021.106508_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tube.2017.11.014","article-title":"A multicentre verification study of the QuantiFERON(\u00ae)-TB Gold Plus assay","volume":"108","author":"Pieterman","year":"2018","journal-title":"Tuberculosis"},{"issue":"6","key":"10.1016\/j.rmed.2021.106508_bib30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jiac.2020.01.011","article-title":"Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus","volume":"26","author":"Tsuyuzaki","year":"2020","journal-title":"J. Infect. Chemother."},{"issue":"1","key":"10.1016\/j.rmed.2021.106508_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1183\/09031936.00030610","article-title":"Interferon-\u03b3 release assays in tuberculosis contacts: is there a window period?","volume":"37","author":"Anibarro","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106508_bib32","series-title":"Manual de Tuberculose e Micobact\u00e9rias N\u00e3o Tuberculosas","author":"Sa\u00fade","year":"2013"},{"issue":"2","key":"10.1016\/j.rmed.2021.106508_bib33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","article-title":"Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice","volume":"187","author":"Metcalfe","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5386","key":"10.1016\/j.rmed.2021.106508_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121002146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121002146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:31:35Z","timestamp":1760617895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611121002146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":33,"alternative-id":["S0954611121002146"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106508","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of CD8+ response in QuantiFERON-TB Gold Plus as a marker of recent infection","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106508"}}